Auxly Cannabis Group (XLY.TO) had lower net income in the first quarter compared to a year earlier, when a deferred tax recovery was included, but revenue was up, the company said Thursday.
For the three months ended March 31, 2026, the company reported net income of near $3.5 million or breakeven per basic and diluted share, compared with $12.1 million or EPS of $0.01, a year earlier.
The company noted Q1 2025 included $8.1 million of deferred tax recovery related to the change in estimated useful life of intangible assets. Excluding the deferred tax recovery, net income decreased by $0.5 million primarily driven by higher fair value loss on biological transformation and inventory. Excluding the impact of fair value adjustments on biological transformation and inventory and the deferred tax recovery in 2025, net income increased $5.8 million primarily due to improved gross profits and the reduction in interest and accretion expenses, partially offset by higher SG&A.
Total net revenue increased to near $39.8 million in Q1, compared with $32.7 million, a year-ago. The growth was primarily driven by higher incremental volumes across the core portfolio, improved pricing across the flower portfolio, partially offset by price compression on vape products, it said.
Also, it had Adjusted EBITDA of $12.3 million, an increase of 65% and representing 31% of net revenue, and cash flow from operations before working capital changes of $11.3 million, an increase of 102%, representing 92% conversion from Adjusted EBITDA. It also cited gross margin on cannabis inventory sold of 55% and an Adjusted EBITDA margin of 31%.
"Our top line success can be attributed to the value proposition offered by Back Forty, contributions from new innovations like South Point and All-in-One Boosted Vapes and improved distribution," said Auxly Chief Executive Hugo Alves.
Auxly expects to allocate between $10 million to $12 million of cash flow from operations towards capital projects at Auxly Leamington in 2026.
Shares of the company were last seen unchanged at $0.14 on the Toronto Stock Exchange.